Feedback / Questions
TTX-810 - Anji Pharma, Broad Institute
https://www.businesswire.com/news/home/20230516005403/en/Trueline-Therapeutics-Announces-Completion-of-IND-Enabling-Studies-for-MCL1-Inhibitor-TTX-810
May 16, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next